Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Capsule Opacification

gefitinib has been researched along with Capsule Opacification in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Elhardt, C; Hillenmayer, A; Kassumeh, S; Kueres, A; Ohlmann, A; Priglinger, SG; von Studnitz, A; Wertheimer, CM1
Eibl-Lindner, K; Kampik, A; Klingenstein, A; Kook, D; Mayer, WJ; Siedlecki, J; Wertheimer, C; Wolf, A1

Other Studies

2 other study(ies) available for gefitinib and Capsule Opacification

ArticleYear
Development of a drug-eluting intraocular lens to deliver epidermal growth factor receptor inhibitor gefitinib for posterior capsule opacification prophylaxis.
    European journal of ophthalmology, 2021, Volume: 31, Issue:2

    Topics: Capsule Opacification; Cell Line; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Epithelial Cells; ErbB Receptors; Fibronectins; Gefitinib; Humans; Hydrophobic and Hydrophilic Interactions; Lenses, Intraocular; Materials Testing; Posterior Capsule of the Lens; Protein Kinase Inhibitors

2021
EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:3

    Topics: Adult; Aged; Capsule Opacification; Cell Line; Cell Movement; Cell Proliferation; Epithelial Cells; ErbB Receptors; Gefitinib; Humans; Lens, Crystalline; Materials Testing; Middle Aged; Neuroglia; Posterior Capsule of the Lens; Protein Kinase Inhibitors; Quinazolines; Retinal Pigment Epithelium

2015